The Life Cycle of Human Papillomaviruses



The life cycle of human papillomaviruses (HPV) is dependent on epithelial differentiation and is regulated by a number of cellular proteins. HPVs infect keratinocytes in the basal layer of the epithelium, and upon cell division, one daughter cell migrates to upper layers while undergoing differentiation. Differentiation triggers the productive phase of the viral life cycle, including viral DNA amplification, late gene expression and virion assembly. Through the actions of viral proteins, infected cells remain active in the cell cycle, creating an environment conducive to late viral events and the production of progeny virions.


Epidermal Growth Factor Receptor Cervical Cancer Viral Genome Viral Life Cycle Early Promoter 



This work was supported by grants to LAL from the NCI and NIAID. CAM was supported by a fellowship from the American Cancer Society (PF-06-177-01-MBC) and a NIH post-doctoral training grant (5T32 AR007593).


  1. Androphy, E.J., Lowy, D.R. and Schiller, J.T. (1987) Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature, 325, 70–73.PubMedGoogle Scholar
  2. Ashrafi, G.H., Haghshenas, M.R., Marchetti, B., O'Brien, P.M. and Campo, M.S. (2005) E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer, 113, 276–283.PubMedGoogle Scholar
  3. Baseman, J.G. and Koutsky, L.A. (2005) The epidemiology of human papillomavirus infections. J Clin Virol, 32 Suppl 1, S16–24.Google Scholar
  4. Baxter, M.K., McPhillips, M.G., Ozato, K. and McBride, A.A. (2005) The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J Virol, 79, 4806–4818.PubMedGoogle Scholar
  5. Bodily, J.M., Alam, S. and Meyers, C. (2006) Regulation of human papillomavirus type 31 late promoter activation and genome amplification by protein kinase C. Virology, 348, 328–340.PubMedGoogle Scholar
  6. Bosch, F.X., Lorincz, A., Munoz, N., Meijer, C.J. and Shah, K.V. (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 55, 244–265.PubMedGoogle Scholar
  7. Bousarghin, L., Touze, A., Sizaret, P.Y. and Coursaget, P. (2003) Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol, 77, 3846–3850.PubMedGoogle Scholar
  8. Bouvard, V., Matlashewski, G., Gu, Z.M., Storey, A. and Banks, L. (1994) The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. Virology, 203, 73–80.PubMedGoogle Scholar
  9. Brehm, A., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A.J. and Kouzarides, T. (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature, 391, 597–601.PubMedGoogle Scholar
  10. Brehm, A., Nielsen, S.J., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A.J. and Kouzarides, T. (1999) The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. Embo J, 18, 2449–2458.PubMedGoogle Scholar
  11. Brimer, N., Lyons, C. and Vande Pol, S.B. (2007) Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein. Virology, 358, 303–310.PubMedGoogle Scholar
  12. Buck, C.B., Thompson, C.D., Pang, Y.Y., Lowy, D.R. and Schiller, J.T. (2005) Maturation of papillomavirus capsids. J Virol, 79, 2839–2846.PubMedGoogle Scholar
  13. Butz, K. and Hoppe-Seyler, F. (1993) Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J Virol, 67, 6476–6486.PubMedGoogle Scholar
  14. Chellappan, S., Kraus, V.B., Kroger, B., Munger, K., Howley, P.M., Phelps, W.C. and Nevins, J.R. (1992) Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA, 89, 4549–4553.PubMedGoogle Scholar
  15. Chen, X.S., Garcea, R.L., Goldberg, I., Casini, G. and Harrison, S.C. (2000) Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell, 5, 557–567.PubMedGoogle Scholar
  16. Cheng, S., Schmidt-Grimminger, D.C., Murant, T., Broker, T.R. and Chow, L.T. (1995) Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev, 9, 2335–2349.PubMedGoogle Scholar
  17. Chong, T., Apt, D., Gloss, B., Isa, M. and Bernard, H.U. (1991) The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription. J Virol, 65, 5933–5943.PubMedGoogle Scholar
  18. Clifford, G., Franceschi, S., Diaz, M., Munoz, N. and Villa, L.L. (2006) Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine, 24 Suppl 3, S26–34.Google Scholar
  19. Clower, R.V., Fisk, J.C. and Melendy, T. (2006) Papillomavirus E1 protein binds to and stimulates human topoisomerase I. J Virol, 80, 1584–1587.PubMedGoogle Scholar
  20. Combita, A.L., Touze, A., Bousarghin, L., Sizaret, P.Y., Munoz, N. and Coursaget, P. (2001) Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate. FEMS Microbiol Lett, 204, 183–188.PubMedGoogle Scholar
  21. Conrad, M., Bubb, V.J. and Schlegel, R. (1993) The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol, 67, 6170–6178.PubMedGoogle Scholar
  22. Cripe, T.P., Haugen, T.H., Turk, J.P., Tabatabai, F., Schmid, P.G., 3rd, Durst, M., Gissmann, L., Roman, A. and Turek, L.P. (1987) Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. Embo J, 6, 3745–3753.PubMedGoogle Scholar
  23. Crook, T., Tidy, J.A. and Vousden, K.H. (1991) Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell, 67, 547–556.PubMedGoogle Scholar
  24. Cumming, S.A., Repellin, C.E., McPhillips, M., Radford, J.C., Clements, J.B. and Graham, S.V. (2002) The human papillomavirus type 31 late 3′ untranslated region contains a complex bipartite negative regulatory element. J Virol, 76, 5993–6003.PubMedGoogle Scholar
  25. Davy, C.E., Ayub, M., Jackson, D.J., Das, P., McIntosh, P. and Doorbar, J. (2006) HPV16 E1–E4 protein is phosphorylated by Cdk2/cyclin A and relocalizes this complex to the cytoplasm. Virology, 349, 230–244.PubMedGoogle Scholar
  26. Davy, C.E., Jackson, D.J., Raj, K., Peh, W.L., Southern, S.A., Das, P., Sorathia, R., Laskey, P., Middleton, K., Nakahara, T., Wang, Q., Masterson, P.J., Lambert, P.F., Cuthill, S., Millar, J.B. and Doorbar, J. (2005) Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes. J Virol, 79, 3998–4011.PubMedGoogle Scholar
  27. Davy, C.E., Jackson, D.J., Wang, Q., Raj, K., Masterson, P.J., Fenner, N.F., Southern, S., Cuthill, S., Millar, J.B. and Doorbar, J. (2002) Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. J Virol, 76, 9806–9818.PubMedGoogle Scholar
  28. Day, P.M., Baker, C.C., Lowy, D.R. and Schiller, J.T. (2004) Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci USA, 101, 14252–14257.PubMedGoogle Scholar
  29. Day, P.M., Lowy, D.R. and Schiller, J.T. (2003) Papillomaviruses infect cells via a clathrin-dependent pathway. Virology, 307, 1–11.PubMedGoogle Scholar
  30. Day, P.M., Roden, R.B., Lowy, D.R. and Schiller, J.T. (1998) The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol, 72, 142–150.PubMedGoogle Scholar
  31. de Villiers, E.M., Fauquet, C., Broker, T.R., Bernard, H.U. and zur Hausen, H. (2004) Classification of papillomaviruses. Virology, 324, 17–27.PubMedGoogle Scholar
  32. del Mar Pena, L.M. and Laimins, L.A. (2001) Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression. J Virol, 75, 10005–10013.PubMedGoogle Scholar
  33. Del Vecchio, A.M., Romanczuk, H., Howley, P.M. and Baker, C.C. (1992) Transient replication of human papillomavirus DNAs. J Virol, 66, 5949–5958.PubMedGoogle Scholar
  34. Demeret, C., Desaintes, C., Yaniv, M. and Thierry, F. (1997) Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J Virol, 71, 9343–9349.PubMedGoogle Scholar
  35. Demeret, C., Yaniv, M. and Thierry, F. (1994) The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter. J Virol, 68, 7075–7082.PubMedGoogle Scholar
  36. Demers, G.W., Halbert, C.L. and Galloway, D.A. (1994) Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology, 198, 169–174.PubMedGoogle Scholar
  37. DiMaio, D. (1991) Transforming activity of bovine and human papillomaviruses in cultured cells. Adv Cancer Res, 56, 133–159.PubMedGoogle Scholar
  38. Disbrow, G.L., Hanover, J.A. and Schlegel, R. (2005) Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. J Virol, 79, 5839–5846.PubMedGoogle Scholar
  39. Disbrow, G.L., Sunitha, I., Baker, C.C., Hanover, J. and Schlegel, R. (2003) Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology, 311, 105–114.PubMedGoogle Scholar
  40. Dong, G., Broker, T.R. and Chow, L.T. (1994) Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J Virol, 68, 1115–1127.PubMedGoogle Scholar
  41. Doorbar, J., Elston, R.C., Napthine, S., Raj, K., Medcalf, E., Jackson, D., Coleman, N., Griffin, H.M., Masterson, P., Stacey, S., Mengistu, Y. and Dunlop, J. (2000) The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus. J Virol, 74, 10081–10095.PubMedGoogle Scholar
  42. Doorbar, J., Ely, S., Sterling, J., McLean, C. and Crawford, L. (1991) Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature, 352, 824–827.PubMedGoogle Scholar
  43. Doorbar, J., Foo, C., Coleman, N., Medcalf, L., Hartley, O., Prospero, T., Napthine, S., Sterling, J., Winter, G. and Griffin, H. (1997) Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology, 238, 40–52.PubMedGoogle Scholar
  44. Doorbar, J., Parton, A., Hartley, K., Banks, L., Crook, T., Stanley, M. and Crawford, L. (1990) Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology, 178, 254–262.PubMedGoogle Scholar
  45. Dostatni, N., Thierry, F. and Yaniv, M. (1988) A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target. Embo J, 7, 3807–3816.PubMedGoogle Scholar
  46. Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes Dev, 12, 2245–2262.PubMedGoogle Scholar
  47. Dyson, N., Howley, P.M., Munger, K. and Harlow, E. (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243, 934–937.PubMedGoogle Scholar
  48. Evander, M., Frazer, I.H., Payne, E., Qi, Y.M., Hengst, K. and McMillan, N.A. (1997) Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol, 71, 2449–2456.PubMedGoogle Scholar
  49. Fanning, A.S. and Anderson, J.M. (1999) PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest, 103, 767–772.PubMedGoogle Scholar
  50. Fay, A., Yutzy, W.H.t., Roden, R.B. and Moroianu, J. (2004) The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding. J Virol, 78, 13447–13454.PubMedGoogle Scholar
  51. Fehrmann, F., Klumpp, D.J. and Laimins, L.A. (2003) Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J Virol, 77, 2819–2831.PubMedGoogle Scholar
  52. Felsani, A., Mileo, A.M. and Paggi, M.G. (2006) Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene, 25, 5277–5285.PubMedGoogle Scholar
  53. Finzer, P., Aguilar-Lemarroy, A. and Rosl, F. (2002) The role of human papillomavirus oncoproteins E6 and E7 in apoptosis. Cancer Lett, 188, 15–24.PubMedGoogle Scholar
  54. Flores, E.R., Allen-Hoffmann, B.L., Lee, D. and Lambert, P.F. (2000) The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle. J Virol, 74, 6622–6631.PubMedGoogle Scholar
  55. Florin, L., Sapp, C., Streeck, R.E. and Sapp, M. (2002a) Assembly and translocation of papillomavirus capsid proteins. J Virol, 76, 10009–10014.Google Scholar
  56. Florin, L., Schafer, F., Sotlar, K., Streeck, R.E. and Sapp, M. (2002b) Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology, 295, 97–107.Google Scholar
  57. Frattini, M.G. and Laimins, L.A. (1994a) Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc Natl Acad Sci USA, 91, 12398–12402.Google Scholar
  58. Frattini, M.G. and Laimins, L.A. (1994b) The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b. Virology, 204, 799–804.Google Scholar
  59. Funk, J.O., Waga, S., Harry, J.B., Espling, E., Stillman, B. and Galloway, D.A. (1997) Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev, 11, 2090–2100.PubMedGoogle Scholar
  60. Furth, P.A. and Baker, C.C. (1991) An element in the bovine papillomavirus late 3′ untranslated region reduces polyadenylated cytoplasmic RNA levels. J Virol, 65, 5806–5812.PubMedGoogle Scholar
  61. Gage, J.R., Meyers, C. and Wettstein, F.O. (1990) The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. J Virol, 64, 723–730.PubMedGoogle Scholar
  62. Garner-Hamrick, P.A., Fostel, J.M., Chien, W.M., Banerjee, N.S., Chow, L.T., Broker, T.R. and Fisher, C. (2004) Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system. J Virol, 78, 9041–9050.PubMedGoogle Scholar
  63. Garnett, T.O. and Duerksen-Hughes, P.J. (2006) Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. Arch Virol, 151, 2321–2335.PubMedGoogle Scholar
  64. Genther, S.M., Sterling, S., Duensing, S., Munger, K., Sattler, C. and Lambert, P.F. (2003) Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J Virol, 77, 2832–2842.PubMedGoogle Scholar
  65. Giri, I. and Yaniv, M. (1988) Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. Embo J, 7, 2823–2829.PubMedGoogle Scholar
  66. Giroglou, T., Florin, L., Schafer, F., Streeck, R.E. and Sapp, M. (2001) Human papillomavirus infection requires cell surface heparan sulfate. J Virol, 75, 1565–1570.PubMedGoogle Scholar
  67. Glaunsinger, B.A., Lee, S.S., Thomas, M., Banks, L. and Javier, R. (2000) Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene, 19, 5270–5280.PubMedGoogle Scholar
  68. Gloss, B. and Bernard, H.U. (1990) The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol, 64, 5577–5584.PubMedGoogle Scholar
  69. Gloss, B., Bernard, H.U., Seedorf, K. and Klock, G. (1987) The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. Embo J, 6, 3735–3743.PubMedGoogle Scholar
  70. Grassmann, K., Rapp, B., Maschek, H., Petry, K.U. and Iftner, T. (1996) Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J Virol, 70, 2339–2349.PubMedGoogle Scholar
  71. Handa, K., Yugawa, T., Narisawa-Saito, M., Ohno, S., Fujita, M. and Kiyono, T. (2007) E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J Virol, 81, 1379–1389.PubMedGoogle Scholar
  72. Harper, D.M., Franco, E.L., Wheeler, C., Ferris, D.G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N.S., Roteli-Martins, C.M., Teixeira, J., Blatter, M.M., Korn, A.P., Quint, W. and Dubin, G. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet, 364, 1757–1765.PubMedGoogle Scholar
  73. Harper, D.M., Franco, E.L., Wheeler, C.M., Moscicki, A.B., Romanowski, B., Roteli-Martins, C.M., Jenkins, D., Schuind, A., Costa Clemens, S.A. and Dubin, G. (2006) Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet, 367, 1247–1255.PubMedGoogle Scholar
  74. Harris, B.Z. and Lim, W.A. (2001) Mechanism and role of PDZ domains in signaling complex assembly. J Cell Sci, 114, 3219–3231.PubMedGoogle Scholar
  75. Hawley-Nelson, P., Androphy, E.J., Lowy, D.R. and Schiller, J.T. (1988) The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. Embo J, 7, 525–531.PubMedGoogle Scholar
  76. He, W., Staples, D., Smith, C. and Fisher, C. (2003) Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7. J Virol, 77, 10566–10574.PubMedGoogle Scholar
  77. Hebner, C.M. and Laimins, L.A. (2006) Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol, 16, 83–97.PubMedGoogle Scholar
  78. Ho, G.Y., Bierman, R., Beardsley, L., Chang, C.J. and Burk, R.D. (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med, 338, 423–428.PubMedGoogle Scholar
  79. Holmgren, S.C., Patterson, N.A., Ozbun, M.A. and Lambert, P.F. (2005) The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J Virol, 79, 3938–3948.PubMedGoogle Scholar
  80. Holowaty, P., Miller, A.B., Rohan, T. and To, T. (1999) Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst, 91, 252–258.PubMedGoogle Scholar
  81. Howley, P.M. (1996) Papillomavirinae: the viruses and their replication. In D.M Knipe, a.P.M.H. (ed.), Fields Virology. Lippincott-Raven Publishers, Philadelphia, pp. 947–978.Google Scholar
  82. Hubert, W.G., Kanaya, T. and Laimins, L.A. (1999) DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal origin. J Virol, 73, 1835–1845.PubMedGoogle Scholar
  83. Hughes, F.J. and Romanos, M.A. (1993) E1 protein of human papillomavirus is a DNA helicase/ATPase. Nucleic Acids Res, 21, 5817–5823.PubMedGoogle Scholar
  84. Huibregtse, J.M., Scheffner, M. and Howley, P.M. (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. Embo J, 10, 4129–4135.PubMedGoogle Scholar
  85. Hummel, M., Hudson, J.B. and Laimins, L.A. (1992) Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol, 66, 6070–6080.PubMedGoogle Scholar
  86. Hummel, M., Lim, H.B. and Laimins, L.A. (1995) Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J Virol, 69, 3381–3388.PubMedGoogle Scholar
  87. Ishiji, T., Lace, M.J., Parkkinen, S., Anderson, R.D., Haugen, T.H., Cripe, T.P., Xiao, J.H., Davidson, I., Chambon, P. and Turek, L.P. (1992) Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. Embo J, 11, 2271–2281.PubMedGoogle Scholar
  88. Jones, D.L., Alani, R.M. and Munger, K. (1997) The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev, 11, 2101–2111.PubMedGoogle Scholar
  89. Jones, D.L. and Munger, K. (1997) Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol, 71, 2905–2912.PubMedGoogle Scholar
  90. Joyce, J.G., Tung, J.S., Przysiecki, C.T., Cook, J.C., Lehman, E.D., Sands, J.A., Jansen, K.U. and Keller, P.M. (1999) The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem, 274, 5810–5822.PubMedGoogle Scholar
  91. Kamper, N., Day, P.M., Nowak, T., Selinka, H.C., Florin, L., Bolscher, J., Hilbig, L., Schiller, J.T. and Sapp, M. (2006) A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol, 80, 759–768.PubMedGoogle Scholar
  92. Kennedy, I.M., Haddow, J.K. and Clements, J.B. (1991) A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J Virol, 65, 2093–2097.PubMedGoogle Scholar
  93. Kirnbauer, R., Booy, F., Cheng, N., Lowy, D.R. and Schiller, J.T. (1992) Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci USA, 89, 12180–12184.PubMedGoogle Scholar
  94. Klingelhutz, A.J., Foster, S.A. and McDougall, J.K. (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature, 380, 79–82.PubMedGoogle Scholar
  95. Klumpp, D.J. and Laimins, L.A. (1999) Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1. Virology, 257, 239–246.PubMedGoogle Scholar
  96. Knight, G.L., Grainger, J.R., Gallimore, P.H. and Roberts, S. (2004) Cooperation between different forms of the human papillomavirus type 1 E4 protein to block cell cycle progression and cellular DNA synthesis. J Virol, 78, 13920–13933.PubMedGoogle Scholar
  97. Koutsky, L. (1997) Epidemiology of genital human papillomavirus infection. Am J Med, 102, 3–8.PubMedGoogle Scholar
  98. Kuhne, C., Gardiol, D., Guarnaccia, C., Amenitsch, H. and Banks, L. (2000) Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6. Oncogene, 19, 5884–5891.PubMedGoogle Scholar
  99. Kurman, R.J., Malkasian, G.D., Jr., Sedlis, A. and Solomon, D. (1991) From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification. Obstet Gynecol, 77, 779–782.PubMedGoogle Scholar
  100. Kuttler, F. and Mai, S. (2007) Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis. Semin Cancer Biol, 17, 56–64.PubMedGoogle Scholar
  101. Kyo, S., Klumpp, D.J., Inoue, M., Kanaya, T. and Laimins, L.A. (1997) Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells. J Gen Virol, 78 (Pt 2), 401–411.PubMedGoogle Scholar
  102. Launay, S., Hermine, O., Fontenay, M., Kroemer, G., Solary, E. and Garrido, C. (2005) Vital functions for lethal caspases. Oncogene, 24, 5137–5148.PubMedGoogle Scholar
  103. Lechner, M.S. and Laimins, L.A. (1994) Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J Virol, 68, 4262–4273.PubMedGoogle Scholar
  104. Lee, C. and Laimins, L.A. (2004) Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J Virol, 78, 12366–12377.PubMedGoogle Scholar
  105. Lee, C., Wooldridge, T.R. and Laimins, L.A. (2007) Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle. Virology, 358, 201–210.PubMedGoogle Scholar
  106. Lee, S.S., Glaunsinger, B., Mantovani, F., Banks, L. and Javier, R.T. (2000) Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol, 74, 9680–9693.PubMedGoogle Scholar
  107. Leechanachai, P., Banks, L., Moreau, F. and Matlashewski, G. (1992) The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene, 7, 19–25.PubMedGoogle Scholar
  108. Li, X. and Coffino, P. (1996) High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J Virol, 70, 4509–4516.PubMedGoogle Scholar
  109. Longworth, M.S. and Laimins, L.A. (2004) The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol, 78, 3533–3541.PubMedGoogle Scholar
  110. Longworth, M.S., Wilson, R. and Laimins, L.A. (2005) HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. Embo J, 24, 1821–1830.PubMedGoogle Scholar
  111. Loo, Y.M. and Melendy, T. (2004) Recruitment of replication protein A by the papillomavirus E1 protein and modulation by single-stranded DNA. J Virol, 78, 1605–1615.PubMedGoogle Scholar
  112. Masterson, P.J., Stanley, M.A., Lewis, A.P. and Romanos, M.A. (1998) A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J Virol, 72, 7407–7419.PubMedGoogle Scholar
  113. McBride, A.A., Byrne, J.C. and Howley, P.M. (1989) E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain. Proc Natl Acad Sci USA, 86, 510–514.PubMedGoogle Scholar
  114. McIntyre, M.C., Ruesch, M.N. and Laimins, L.A. (1996) Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology, 215, 73–82.PubMedGoogle Scholar
  115. McMillan, N.A., Payne, E., Frazer, I.H. and Evander, M. (1999) Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology, 261, 271–279.PubMedGoogle Scholar
  116. Modis, Y., Trus, B.L. and Harrison, S.C. (2002) Atomic model of the papillomavirus capsid. Embo J, 21, 4754–4762.PubMedGoogle Scholar
  117. Mohr, I.J., Clark, R., Sun, S., Androphy, E.J., MacPherson, P. and Botchan, M.R. (1990) Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science, 250, 1694–1699.PubMedGoogle Scholar
  118. Muller, M., Gissmann, L., Cristiano, R.J., Sun, X.Y., Frazer, I.H., Jenson, A.B., Alonso, A., Zentgraf, H. and Zhou, J. (1995) Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol, 69, 948–954.PubMedGoogle Scholar
  119. Munger, K., Werness, B.A., Dyson, N., Phelps, W.C., Harlow, E. and Howley, P.M. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. Embo J, 8, 4099–4105.PubMedGoogle Scholar
  120. Nakahara, T., Nishimura, A., Tanaka, M., Ueno, T., Ishimoto, A. and Sakai, H. (2002) Modulation of the cell division cycle by human papillomavirus type 18 E4. J Virol, 76, 10914–10920.PubMedGoogle Scholar
  121. Nakahara, T., Peh, W.L., Doorbar, J., Lee, D. and Lambert, P.F. (2005) Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle. J Virol, 79, 13150–13165.PubMedGoogle Scholar
  122. Nasseri, M., Hirochika, R., Broker, T.R. and Chow, L.T. (1987) A human papilloma virus type 11 transcript encoding an E1–E4 protein. Virology, 159, 433–439.PubMedGoogle Scholar
  123. Nevins, J.R. (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science, 258, 424–429.PubMedGoogle Scholar
  124. Oberg, D., Collier, B., Zhao, X. and Schwartz, S. (2003) Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J Virol, 77, 11674–11684.PubMedGoogle Scholar
  125. O'Connor, M. and Bernard, H.U. (1995) Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology, 207, 77–88.PubMedGoogle Scholar
  126. Oh, S.T., Longworth, M.S. and Laimins, L.A. (2004) Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J Virol, 78, 2620–2626.PubMedGoogle Scholar
  127. Okun, M.M., Day, P.M., Greenstone, H.L., Booy, F.P., Lowy, D.R., Schiller, J.T. and Roden, R.B. (2001) L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation. J Virol, 75, 4332–4342.PubMedGoogle Scholar
  128. Ozbun, M.A. and Meyers, C. (1997) Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J Virol, 71, 5161–5172.PubMedGoogle Scholar
  129. Ozbun, M.A. and Meyers, C. (1998a) Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology, 248, 218–230.Google Scholar
  130. Ozbun, M.A. and Meyers, C. (1998b) Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J Virol, 72, 2715–2722.Google Scholar
  131. Parish, J.L., Bean, A.M., Park, R.B. and Androphy, E.J. (2006) ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes and viral genome maintenance. Mol Cell, 24, 867–876.PubMedGoogle Scholar
  132. Park, P., Copeland, W., Yang, L., Wang, T., Botchan, M.R. and Mohr, I.J. (1994) The cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicase. Proc Natl Acad Sci USA, 91, 8700–8704.PubMedGoogle Scholar
  133. Park, R.B. and Androphy, E.J. (2002) Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J Virol, 76, 11359–11364.PubMedGoogle Scholar
  134. Parkin, D.M. and Bray, F. (2006) Chapter 2: The burden of HPV-related cancers. Vaccine, 24 Suppl 3, S11–25.Google Scholar
  135. Patel, D., Huang, S.M., Baglia, L.A. and McCance, D.J. (1999) The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. Embo J, 18, 5061–5072.PubMedGoogle Scholar
  136. Phelps, W.C., Yee, C.L., Munger, K. and Howley, P.M. (1988) The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell, 53, 539–547.PubMedGoogle Scholar
  137. Raj, K. and Stanley, M.A. (1995) The ATP-binding and ATPase activities of human papillomavirus type 16 E1 are significantly weakened by the absence of prolines in its ATP-binding domain. J Gen Virol, 76 ( Pt 12), 2949–2956.PubMedGoogle Scholar
  138. Remm, M., Remm, A. and Ustav, M. (1999) Human papillomavirus type 18 E1 protein is translated from polycistronic mRNA by a discontinuous scanning mechanism. J Virol, 73, 3062–3070.PubMedGoogle Scholar
  139. Richards, R.M., Lowy, D.R., Schiller, J.T. and Day, P.M. (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci USA, 103, 1522–1527.PubMedGoogle Scholar
  140. Roberts, S., Ashmole, I., Gibson, L.J., Rookes, S.M., Barton, G.J. and Gallimore, P.H. (1994) Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells. J Virol, 68, 6432–6445.PubMedGoogle Scholar
  141. Roden, R.B., Kirnbauer, R., Jenson, A.B., Lowy, D.R. and Schiller, J.T. (1994) Interaction of papillomaviruses with the cell surface. J Virol, 68, 7260–7266.PubMedGoogle Scholar
  142. Ruesch, M.N. and Laimins, L.A. (1997) Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity. J Virol, 71, 5570–5578.PubMedGoogle Scholar
  143. Ruesch, M.N. and Laimins, L.A. (1998) Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium. Virology, 250, 19–29.PubMedGoogle Scholar
  144. Sanders, C.M. and Stenlund, A. (1998) Recruitment and loading of the E1 initiator protein: an ATP-dependent process catalysed by a transcription factor. Embo J, 17, 7044–7055.PubMedGoogle Scholar
  145. Sanders, C.M. and Stenlund, A. (2000) Transcription factor-dependent loading of the E1 initiator reveals modular assembly of the papillomavirus origin melting complex. J Biol Chem, 275, 3522–3534.PubMedGoogle Scholar
  146. Scheffner, M., Huibregtse, J.M., Vierstra, R.D. and Howley, P.M. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75, 495–505.PubMedGoogle Scholar
  147. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J. and Howley, P.M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129–1136.PubMedGoogle Scholar
  148. Schiller, J.T., Vass, W.C., Vousden, K.H. and Lowy, D.R. (1986) E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene. J Virol, 57, 1–6.PubMedGoogle Scholar
  149. Sedman, J. and Stenlund, A. (1995) Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. Embo J, 14, 6218–6228.PubMedGoogle Scholar
  150. Selinka, H.C., Giroglou, T. and Sapp, M. (2002) Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology, 299, 279–287.PubMedGoogle Scholar
  151. Sen, E., Alam, S. and Meyers, C. (2004) Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle. J Virol, 78, 612–629.PubMedGoogle Scholar
  152. Shafti-Keramat, S., Handisurya, A., Kriehuber, E., Meneguzzi, G., Slupetzky, K. and Kirnbauer, R. (2003) Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol, 77, 13125–13135.PubMedGoogle Scholar
  153. Sherr, C.J. and Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev, 9, 1149–1163.PubMedGoogle Scholar
  154. Sibbet, G., Romero-Graillet, C., Meneguzzi, G. and Campo, M.S. (2000) alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4. J Gen Virol, 81, 327–334.PubMedGoogle Scholar
  155. Singer, A. (1995) Cervical cancer screening: state of the art. Baillieres Clin Obstet Gynaecol, 9, 39–64.PubMedGoogle Scholar
  156. Soeda, E., Ferran, M.C., Baker, C.C. and McBride, A.A. (2006) Repression of HPV16 early region transcription by the E2 protein. Virology, 351, 29–41.PubMedGoogle Scholar
  157. Sokolowski, M., Zhao, C., Tan, W. and Schwartz, S. (1997) AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors. Oncogene, 15, 2303–2319.PubMedGoogle Scholar
  158. Spink, K.M. and Laimins, L.A. (2005) Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification. J Virol, 79, 4918–4926.PubMedGoogle Scholar
  159. Steger, G. and Corbach, S. (1997) Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol, 71, 50–58.PubMedGoogle Scholar
  160. Stenlund, A. (2003) Initiation of DNA replication: lessons from viral initiator proteins. Nat Rev Mol Cell Biol, 4, 777–785.PubMedGoogle Scholar
  161. Straight, S.W., Herman, B. and McCance, D.J. (1995) The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol, 69, 3185–3192.PubMedGoogle Scholar
  162. Straight, S.W., Hinkle, P.M., Jewers, R.J. and McCance, D.J. (1993) The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol, 67, 4521–4532.PubMedGoogle Scholar
  163. Stubenrauch, F. and Laimins, L.A. (1999) Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol, 9, 379–386.PubMedGoogle Scholar
  164. Stubenrauch, F., Lim, H.B. and Laimins, L.A. (1998) Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J Virol, 72, 1071–1077.PubMedGoogle Scholar
  165. Tan, S.H., Leong, L.E., Walker, P.A. and Bernard, H.U. (1994) The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol, 68, 6411–6420.PubMedGoogle Scholar
  166. Tan, W., Felber, B.K., Zolotukhin, A.S., Pavlakis, G.N. and Schwartz, S. (1995) Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J Virol, 69, 5607–5620.PubMedGoogle Scholar
  167. Tan, W. and Schwartz, S. (1995) The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3′ untranslated region. J Virol, 69, 2932–2945.PubMedGoogle Scholar
  168. Terhune, S.S., Milcarek, C. and Laimins, L.A. (1999) Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle. J Virol, 73, 7185–7192.PubMedGoogle Scholar
  169. Thierry, F., Heard, J.M., Dartmann, K. and Yaniv, M. (1987) Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens. J Virol, 61, 134–142.PubMedGoogle Scholar
  170. Thomas, J.T., Hubert, W.G., Ruesch, M.N. and Laimins, L.A. (1999) Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc Natl Acad Sci USA, 96, 8449–8454.PubMedGoogle Scholar
  171. Thomas, J.T., Oh, S.T., Terhune, S.S. and Laimins, L.A. (2001) Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J Virol, 75, 7564–7571.PubMedGoogle Scholar
  172. Thomas, M.C. and Chiang, C.M. (2005) E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol Cell, 17, 251–264.PubMedGoogle Scholar
  173. Tommasino, M., Adamczewski, J.P., Carlotti, F., Barth, C.F., Manetti, R., Contorni, M., Cavalieri, F., Hunt, T. and Crawford, L. (1993) HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene, 8, 195–202.PubMedGoogle Scholar
  174. Ustav, M. and Stenlund, A. (1991) Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. Embo J, 10, 449–457.PubMedGoogle Scholar
  175. Ustav, M., Ustav, E., Szymanski, P. and Stenlund, A. (1991) Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. Embo J, 10, 4321–4329.PubMedGoogle Scholar
  176. Valle, G.F. and Banks, L. (1995) The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells. J Gen Virol, 76 ( Pt 5), 1239–1245.PubMedGoogle Scholar
  177. Veldman, T., Horikawa, I., Barrett, J.C. and Schlegel, R. (2001) Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol, 75, 4467–4472.PubMedGoogle Scholar
  178. Villa, L.L., Costa, R.L., Petta, C.A., Andrade, R.P., Ault, K.A., Giuliano, A.R., Wheeler, C.M., Koutsky, L.A., Malm, C., Lehtinen, M., Skjeldestad, F.E., Olsson, S.E., Steinwall, M., Brown, D.R., Kurman, R.J., Ronnett, B.M., Stoler, M.H., Ferenczy, A., Harper, D.M., Tamms, G.M., Yu, J., Lupinacci, L., Railkar, R., Taddeo, F.J., Jansen, K.U., Esser, M.T., Sings, H.L., Saah, A.J. and Barr, E. (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol, 6, 271–278.PubMedGoogle Scholar
  179. Volpers, C., Unckell, F., Schirmacher, P., Streeck, R.E. and Sapp, M. (1995) Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol, 69, 3258–3264.PubMedGoogle Scholar
  180. Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., Snijders, P.J., Peto, J., Meijer, C.J. and Munoz, N. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12–19.PubMedGoogle Scholar
  181. Wallin, K.L., Wiklund, F., Angstrom, T., Bergman, F., Stendahl, U., Wadell, G., Hallmans, G. and Dillner, J. (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med, 341, 1633–1638.PubMedGoogle Scholar
  182. Wang, Q., Griffin, H., Southern, S., Jackson, D., Martin, A., McIntosh, P., Davy, C., Masterson, P.J., Walker, P.A., Laskey, P., Omary, M.B. and Doorbar, J. (2004) Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol, 78, 821–833.PubMedGoogle Scholar
  183. Webb, A. and Kaur, P. (2006) Epidermal stem cells. Front Biosci, 11, 1031–1041.PubMedGoogle Scholar
  184. Werness, B.A., Levine, A.J. and Howley, P.M. (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76–79.PubMedGoogle Scholar
  185. Wiley, D. and Masongsong, E. (2006) Human papillomavirus: the burden of infection. Obstet Gynecol Surv, 61, S3–14.PubMedGoogle Scholar
  186. Wilson, R., Fehrmann, F. and Laimins, L.A. (2005) Role of the E1–E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31. J Virol, 79, 6732–6740.PubMedGoogle Scholar
  187. Wilson, R., Ryan, G.B., Knight, G.L., Laimins, L.A. and Roberts, S. (2007) The full-length E1;E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. Virology.Google Scholar
  188. Yang, R., Day, P.M., Yutzy, W.H.t., Lin, K.Y., Hung, C.F. and Roden, R.B. (2003) Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J Virol, 77, 3531–3541.PubMedGoogle Scholar
  189. You, J., Croyle, J.L., Nishimura, A., Ozato, K. and Howley, P.M. (2004) Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell, 117, 349–360.PubMedGoogle Scholar
  190. Zerfass-Thome, K., Zwerschke, W., Mannhardt, B., Tindle, R., Botz, J.W. and Jansen-Durr, P. (1996) Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene, 13, 2323–2330.PubMedGoogle Scholar
  191. Zhang, B., Chen, W. and Roman, A. (2006) The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci USA, 103, 437–442.PubMedGoogle Scholar
  192. Zhang, B., Li, P., Wang, E., Brahmi, Z., Dunn, K.W., Blum, J.S. and Roman, A. (2003) The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Virology, 310, 100–108.PubMedGoogle Scholar
  193. Zhao, K.N., Gu, W., Fang, N.X., Saunders, N.A. and Frazer, I.H. (2005) Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo. Mol Cell Biol, 25, 8643–8655.PubMedGoogle Scholar
  194. Zhao, K.N., Liu, W.J. and Frazer, I.H. (2003) Codon usage bias and A+T content variation in human papillomavirus genomes. Virus Res, 98, 95–104.PubMedGoogle Scholar
  195. Zheng, Z.M. and Baker, C.C. (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci, 11, 2286–2302.PubMedGoogle Scholar
  196. Zhou, J., Liu, W.J., Peng, S.W., Sun, X.Y. and Frazer, I. (1999) Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J Virol, 73, 4972–4982.PubMedGoogle Scholar
  197. Zhou, J., Sun, X.Y., Stenzel, D.J. and Frazer, I.H. (1991) Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology, 185, 251–257.PubMedGoogle Scholar
  198. Zielinski, G.D., Snijders, P.J., Rozendaal, L., Voorhorst, F.J., van der Linden, H.C., Runsink, A.P., de Schipper, F.A. and Meijer, C.J. (2001) HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer, 85, 398–404.PubMedGoogle Scholar
  199. Zimmermann, H., Degenkolbe, R., Bernard, H.U. and O'Connor, M.J. (1999) The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol, 73, 6209–6219.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of Microbiology-ImmunologyNorthwestern UniversityChicagoUSA

Personalised recommendations